Introduction
A perioperative hemodynamic goal-directed therapy (GDT) has been advocated in patients undergoing high risk-surgery in order to reduce postoperative complications. Nevertheless, the benefits of GDT in surgical patients are controversial and may lead to an overuse of fluids, inotropic agents and blood transfusion.
Objectives
The aim of this randomized, controlled, single-center trial was to assess the effect of GDT after abdominal oncology surgery on the incidence of major postoperative complications. We also evaluated the requirements of fluid, inotropic agents, blood transfusion and the intensive care unit (ICU) and hospital length of stay between groups.
Methods
We randomly assigned patients admitted to the ICU after major abdominal oncology surgery to receive either GDT protocol or usual care. The GDT protocol involved hemodynamic optimization aimed at a target of a cardiac index >2.5 L/minute/m2 (by minimally invasive cardiac output monitoring) and a mean arterial pressure of 70 mmHg through a three-step approach: fluid therapy of 250 ml albumin 4% in lactated Ringer´s solution, dobutamine infusion up to a dose of 20 µg/kg/minute, and red blood cell transfusion to reach a hemoglobin level above 8g/dL. The primary outcome was a 30-day composite endpoint of acute kidney injury, major cardiovascular complications, adult respiratory distress syndrome, septic shock, reoperation and mortality.
Results
Of the 125 enrolled patients, 62 were assigned to GDTgroup and 63 to the usual-care group. There was no difference between groups regarding the amount of fluids received during 8 hours (1345 mL vs. 1100 mL 
Conclusions
In surgical critically ill patients admitted to the ICU after major abdominal oncology surgery, a GDT protocol did not reduce the incidence of major postoperative complications at 30 days. Also, the GDT protocol was associated with an overuse of inotropic agents. (ClinicalTrials.gov number, NCT 01946269.)
